LT3169307T - Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną - Google Patents

Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną

Info

Publication number
LT3169307T
LT3169307T LTEP15738918.0T LT15738918T LT3169307T LT 3169307 T LT3169307 T LT 3169307T LT 15738918 T LT15738918 T LT 15738918T LT 3169307 T LT3169307 T LT 3169307T
Authority
LT
Lithuania
Prior art keywords
paracetamol
ibuprofen
aqueous formulation
formulation
aqueous
Prior art date
Application number
LTEP15738918.0T
Other languages
English (en)
Inventor
Thomas Jacobsen
Original Assignee
Hyloris Pharmaceuticals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyloris Pharmaceuticals SA filed Critical Hyloris Pharmaceuticals SA
Publication of LT3169307T publication Critical patent/LT3169307T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1407—Infusion of two or more substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
LTEP15738918.0T 2014-07-18 2015-07-17 Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną LT3169307T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2014/065544 WO2016008546A1 (en) 2014-07-18 2014-07-18 Aqueous formulation comprising paracetamol and ibuprofen
PCT/EP2015/066466 WO2016009067A1 (en) 2014-07-18 2015-07-17 Aqueous formulation comprising paracetamol and ibuprofen

Publications (1)

Publication Number Publication Date
LT3169307T true LT3169307T (lt) 2020-07-10

Family

ID=51211244

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP15738918.0T LT3169307T (lt) 2014-07-18 2015-07-17 Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną

Country Status (26)

Country Link
US (4) US11219609B2 (lt)
EP (2) EP3656377A1 (lt)
JP (2) JP6745798B2 (lt)
CN (2) CN113018258A (lt)
AR (1) AR100365A1 (lt)
AU (1) AU2015289035B2 (lt)
BR (1) BR112017001093B1 (lt)
CA (1) CA2955557C (lt)
CY (1) CY1122899T1 (lt)
DK (1) DK3169307T3 (lt)
EA (1) EA036212B1 (lt)
ES (1) ES2791349T3 (lt)
HR (1) HRP20200704T1 (lt)
HU (1) HUE048881T2 (lt)
IL (1) IL250112B2 (lt)
LT (1) LT3169307T (lt)
MX (1) MX2017000764A (lt)
MY (1) MY192813A (lt)
NZ (1) NZ728796A (lt)
PL (1) PL3169307T3 (lt)
PT (1) PT3169307T (lt)
RS (1) RS60289B1 (lt)
SG (1) SG11201700421RA (lt)
SI (1) SI3169307T1 (lt)
TN (1) TN2017000011A1 (lt)
WO (2) WO2016008546A1 (lt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018025128A1 (en) * 2016-08-02 2018-02-08 Jamil Irfan Stable ibuprofen injectable composition
DE102017202510A1 (de) 2017-02-16 2018-08-16 Eurozyto Gmbh Behältnis zur Bereitstellung patientenspezifischer Arzneimittel
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
WO2022178018A1 (en) * 2021-02-19 2022-08-25 Nevakar Injectables Inc. Liquid unit dosage forms for treatment of pain
CN114062554B (zh) * 2021-11-20 2023-07-21 山东百诺医药股份有限公司 一种同时测定对乙酰氨基酚布洛芬有关物质的分析方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
US20060100578A1 (en) * 2004-09-13 2006-05-11 Tandem Medical, Inc. Medication delivery apparatus and methods for intravenous infusions
CA2711211A1 (en) 2008-01-03 2009-07-09 Aft Pharmaceuticals Ltd. Oral pharmaceutical suspension comprising paracetamol and ibuprofen
CH702339B1 (de) 2008-10-14 2016-06-15 Aft Pharmaceuticals Ltd Kombination von Paracetamol und Ibuprofen zur Behandlung von Osteoarthritis.
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US8404748B2 (en) * 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
EP2389923B1 (en) * 2010-05-19 2013-01-30 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Stable ready to use injectable paracetamol formulation
JP2013541583A (ja) 2010-11-04 2013-11-14 エイエフティ ファーマスーティカルズ リミテッド 組み合わせ組成物
BE1020614A5 (nl) * 2012-01-27 2014-01-07 Hubert De Backer Nv Injectiespuit.
DK2825039T3 (en) * 2012-03-16 2017-11-27 Cumberland Pharmaceuticals Inc Injectable ibuprofen formulation
US9072661B2 (en) * 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF

Also Published As

Publication number Publication date
CN106794163A (zh) 2017-05-31
US20170209398A1 (en) 2017-07-27
CY1122899T1 (el) 2021-05-05
TN2017000011A1 (en) 2018-07-04
AR100365A1 (es) 2016-09-28
CN113018258A (zh) 2021-06-25
CN106794163B (zh) 2021-03-26
ES2791349T3 (es) 2020-11-04
PT3169307T (pt) 2020-05-18
JP2017522382A (ja) 2017-08-10
AU2015289035A1 (en) 2017-02-23
EP3656377A1 (en) 2020-05-27
SI3169307T1 (sl) 2020-07-31
DK3169307T3 (da) 2020-05-11
IL250112A0 (en) 2017-03-30
US11389416B2 (en) 2022-07-19
US12083087B2 (en) 2024-09-10
CA2955557A1 (en) 2016-01-21
MY192813A (en) 2022-09-09
EA201790223A1 (ru) 2017-05-31
JP6892494B2 (ja) 2021-06-23
WO2016008546A1 (en) 2016-01-21
SG11201700421RA (en) 2017-02-27
RS60289B1 (sr) 2020-07-31
PL3169307T3 (pl) 2020-09-21
WO2016009067A1 (en) 2016-01-21
EP3169307B1 (en) 2020-02-19
HUE048881T2 (hu) 2020-08-28
BR112017001093A2 (pt) 2017-11-14
IL250112B (en) 2022-10-01
JP6745798B2 (ja) 2020-08-26
US20190343785A1 (en) 2019-11-14
MX2017000764A (es) 2017-08-18
US20230181502A1 (en) 2023-06-15
NZ728796A (en) 2023-05-26
US20220031645A1 (en) 2022-02-03
AU2015289035B2 (en) 2020-03-26
US11213498B2 (en) 2022-01-04
BR112017001093B1 (pt) 2023-01-31
CA2955557C (en) 2021-06-22
EP3169307A1 (en) 2017-05-24
HRP20200704T1 (hr) 2020-07-24
IL250112B2 (en) 2023-02-01
EA036212B1 (ru) 2020-10-14
JP2020059740A (ja) 2020-04-16
US11219609B2 (en) 2022-01-11

Similar Documents

Publication Publication Date Title
HK1244000B (zh) 多環氨基甲酰吡啶酮化合物及其藥物用途
EP3302442A4 (en) PHARMACEUTICAL FORM AND USE THEREOF
IL250331B (en) Flagellin-based agents and uses including effective vaccination
IL250112B (en) Aqueous composition containing paracetamol and ibuprofen
EP3106495A4 (en) Nanoparticle-containing solution and use thereof
IL251940A0 (en) Dihydropyrimidin-2-one compounds and their medical use
HK1243077A1 (zh) 呱啶基吡唑並嘧啶酮及其用途
TWI563001B (en) Disintegrin variants and pharmaceutical uses thereof
HK1219982A1 (zh) 轉錄激活因子樣效應因子核酸酶及其應用
PT3011831T (pt) Limoneno: formulação e utilização inseticida
PL3429555T3 (pl) Preparat mesny i jego zastosowanie
PT3129398T (pt) Novos agentes médicos e usos dos mesmos
SG10201501373WA (en) Contrast Agent And Applications Thereof
GB201513940D0 (en) Catalyst and use thereof
IL255024A0 (en) Hydroxamic acids and their uses
IL252577A0 (en) Preservative-free treprostinil preparations and methods and devices for their use
DK3145548T3 (en) Aqueous gel composition and its use
SG11201700191PA (en) Microbiocides and uses thereof
PL3094338T3 (pl) Oznaczenie i lek
GB201420805D0 (en) Ligatures and use thereof
GB2545167B (en) Cloches and use thereof
PL3229772T3 (pl) 6-arylo-9-glikozylopuryny i ich zastosowanie
GB201419354D0 (en) Pharmaceutical extracts and uses thereof